Low risk and high risk Human Papillomaviruses (HPVs) and cervical cancer in Zimbabwe: Epidemiological evidence

Central African Journal of Medicine

Volumn 47, Issue 2, 2001, Pages 32-35

  Chirara, M ^a   Stanczuk, G A ^a   Tswana, S A ^a   Nystrom, L ^b   Bergstrom, S ^c   Moyo, S R ^a   Nzara, M J ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b UMEÅ UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION; ZIMBABWE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; ZIMBABWE;

EID: 0035262542     PISSN: 00089176     EISSN: None     Source Type: Journal    
DOI: 10.4314/cajm.v47i2.8589     Document Type: Article

References (15)

1. Womack SD, Chirenje ZM, Blumenthal PD, Gaffikin L, McGrath J A, Chipato T, et al. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe Br J Obstet Gynecol 2000;107:33-8.
2. Alami RM, Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol 1998;16:330-7.
3. de Villiers E. M. Human pathogenic papillomavirus types: an update. Curr Opin Microbiol Immunol 1994;108:2-9.
4. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific HPV DNA as predictor of high grade cervical intraepithelial neoplasia. Br J Cancer 1994;69:167-71.
5. Koutsky LA, Holmes KK, Critchow MS, Steven CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
6. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical cells of undetermined significance. Am J Obstet Gynaecol 1995;172:946-54.
7. Sherlaw-Johnson C, Gullivan S, Jenkins D. Evaluating cervical cancer screening programmes for developing countries. Int J Cancer 1997; 72:210-6.
8. Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, et al. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer 2000;85:206-10.
9. Cooper K, Herrington CS, Garaham AK, Evans MF, McGee J. In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa. J Clin Pathol 1991;44:406-9.
10. Ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, et al. Human papillomavirus (HPV) infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992;51:515-21.
11. Durst M, Gissman L, Ikenburg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. PNAS USA 1983;80:3812-15.
12. Macnab JCM, Walkinshaw SA, Cordiner JW, Clemens JB. Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. New Engl J Med 1986;315:1052-8.
13. Meanwell CA., Cox MF, Blackledge G, Maitland NJ. HPV 16 in normal and malignant cervical epithelium: Implications for the aetiology and behaviour of cervical neoplasia. Lancet 1987;1:703-7077.
14. Williamson A-L, Brink NS, Dehaeck CMC, Ovens S, Soeters R, Rybicki E P. Typing of human papillomavirus in cervical carcinoma biopsies from Cape Town. J Med Virol 1994;43:231-7.
15. Backe J, Roos T, Mulfinger L, Martius J. Prelevance of human papillomavirus DNA in cervical tissue. Retrospective analysis of 855 cervical biopsies. Arch Gynaecol Obstet 1997;259:69-77.